At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PODD Insulet
Post-Mkt 07-10 18:41:50 EDT
161.28
+2.99
+1.89%
盘后161.28
+0.000.00%
16:20 EDT
High161.82Low158.30Vol723.31K
Open159.21D1 Closing158.29Amplitude2.22%
Mkt Cap11.17BTradable Cap11.17BTotal Shares69.26M
T/O116.34MT/O Rate1.04%Tradable Shares69.26M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Insulet Corp. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  05:16
Insulet Corp. Stock Outperforms Competitors on Strong Trading Day
Stifel Adjusts Price Target on Insulet to $225 From $250
MT Newswires Live  ·  07-10 19:28
Stifel Adjusts Price Target on Insulet to $225 From $250
Insulet price target lowered to $225 from $250 at Stifel
TIPRANKS  ·  07-10 19:20
Insulet price target lowered to $225 from $250 at Stifel
Insulet Corp. Stock Underperforms Wednesday When Compared to Competitors
Dow Jones  ·  07-09 05:13
Insulet Corp. Stock Underperforms Wednesday When Compared to Competitors
Insulet Corporation Faces Federal Securities Lawsuit Over Alleged Manufacturing Defects in Omnipod Products
TIPRANKS  ·  07-09 03:52
Insulet Corporation Faces Federal Securities Lawsuit Over Alleged Manufacturing Defects in Omnipod Products
Insulet is Maintained at Neutral by Citigroup
Dow Jones  ·  07-08 23:45
Insulet is Maintained at Neutral by Citigroup
Citigroup Adjusts Insulet Price Target to $172 From $165
MT Newswires Live  ·  07-08 21:11
Citigroup Adjusts Insulet Price Target to $172 From $165
Insulet price target raised to $172 from $165 at Citi
TIPRANKS  ·  07-08 18:41
Insulet price target raised to $172 from $165 at Citi
Citi Sticks to Their Hold Rating for Insulet (PODD)
TIPRANKS  ·  07-08 17:46
Citi Sticks to Their Hold Rating for Insulet (PODD)
Insulet Corp. Stock Underperforms Monday When Compared to Competitors
Dow Jones  ·  07-07
Insulet Corp. Stock Underperforms Monday When Compared to Competitors
Dexcom Inc. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  07-07
Dexcom Inc. Stock Outperforms Competitors on Strong Trading Day
Insulet is Maintained at Outperform by Evercore ISI Group
Dow Jones  ·  07-07
Insulet is Maintained at Outperform by Evercore ISI Group
Evercore ISI Adjusts Price Target on Insulet to $180 From $200
MT Newswires Live  ·  07-06
Evercore ISI Adjusts Price Target on Insulet to $180 From $200
Insulet Corp. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  07-03
Insulet Corp. Stock Outperforms Competitors on Strong Trading Day
Insulet Files Form 3 Disclosing Jonathan Jay Mazelsky as Director Beneficial Owner
Reuters  ·  07-03
Insulet Files Form 3 Disclosing Jonathan Jay Mazelsky as Director Beneficial Owner
Insulet Recalls Omnipod Pods After Insulin-Delivery Failure Risk Identified, FDA Says
MT Newswires Live  ·  07-03
Insulet Recalls Omnipod Pods After Insulin-Delivery Failure Risk Identified, FDA Says
FDA says Insulet recalled certain Omnipod Pods
TIPRANKS  ·  07-03
FDA says Insulet recalled certain Omnipod Pods
US FDA Classifies Insulet Omnipod Pods Recall as Class I Due to Serious Injury Risk
Reuters  ·  07-03
US FDA Classifies Insulet Omnipod Pods Recall as Class I Due to Serious Injury Risk
US FDA - Insulet Reports 24 Serious Injuries, no Deaths from Omnipod Pods Issue as of May 20
THOMSON REUTERS  ·  07-03
US FDA - Insulet Reports 24 Serious Injuries, no Deaths from Omnipod Pods Issue as of May 20
Insulet’s EVOLVE Trial Targets Big Type 2 Diabetes Opportunity With Omnipod M
TIPRANKS  ·  07-03
Insulet’s EVOLVE Trial Targets Big Type 2 Diabetes Opportunity With Omnipod M

Introduction

Company Name.
Insulet
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Issue price:
--